Assessment of antigen processing and presentation of CD40 activated B cells
Assessment of antigen processing and presentation of CD40 activated B cells
批准号:
21890147
负责人:
KONDO Eisei
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It has been demonstrated that CD40-activated B (CD40-B) cells are potent antigen presenting cells that can be expanded significantly ex vivo.Several methods to antigen load CD40-Bs to generate viral or tumor-antigen specific CD8+ T cells have been identified. However, it is unclear how CD40-Bs take up and process exogenous antigen in an B cell receptor independent manner to stimulate CD4+ T cells. CD4+ T cells specific for multiple epitopes were successfully generated in stimulation with CD40-B cells pulsed with recombinant protein. In addition, CD40-Bs were able to be easily transfected with in vitro transcribed-mRNA. CD40-B cells are thought to be useful in cellular therapy.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cyclin D1 as a widely expressed tumor antigen : generation of high avidity CTL in an autologous setting
细胞周期蛋白 D1 作为广泛表达的肿瘤抗原:在自体环境中生成高亲和力 CTL
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Kiba W, Imazato S, Takahashi Y, Yoshioka S, Ebisu S, Nakano T., 近藤英生]
通讯作者:
近藤英生
Identification of native, immunogenic peptides from Cyclin D1.
从 Cyclin D1 中鉴定天然免疫原性肽。
DOI:
--
发表时间:
2010
期刊:
Leukemia 24
影响因子:
--
作者:
[von Bergwelt-Baildon MS, Shimabukuro-Vornhagen A, Wendtner CM, Kondo E]
通讯作者:
Kondo E
Cyclin A2特異的High-avidity CTLの樹立
Cyclin A2特异性高亲和力CTL的建立
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Klein-Gonzalez N, Kondo E, von Bergwelt-Baildon MS., Kobashi H, 近藤英生]
通讯作者:
近藤英生
Cyclins against cancer : a novel family of tumor antigens?
抗癌细胞周期蛋白:一个新的肿瘤抗原家族?
DOI:
--
发表时间:
2010
期刊:
Immunotherapy. 2
影响因子:
--
作者:
[Klein-Gonzalez N, Kondo E, von Bergwelt-Baildon MS.]
通讯作者:
von Bergwelt-Baildon MS.
がんの分子標的と治療薬事典
癌症分子靶点及治疗药物百科全书
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[近藤英生, 他]
通讯作者:
他
Development of monitoring systems for CMVpp65 specific CTLs restricted to each HLA class I.
-
批准号:23591418
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:KONDO Eisei
-
依托单位: